MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ
14.89
+0.24
+1.62%
Opening 09:30 10/03 EDT
OPEN
14.89
PREV CLOSE
14.65
HIGH
14.89
LOW
14.89
VOLUME
15
TURNOVER
223
52 WEEK HIGH
30.49
52 WEEK LOW
12.76
TOTAL ASSET
20.23M
YTD YIELD
-48.41%
1D
5D
1M
3M
1Y
5Y
Hedge Funds Flip to Dollar Bears on Bets Peak of Rally Is Over
Bloomberg · 08/15 02:23
Stocks Set to Rise as Traders Await Key China Data: Markets Wrap
Bloomberg · 08/14 23:37
Gold Drops as Investors Prepare for Fed’s Next Jumbo Rate Hike
Bloomberg · 07/25 01:02
Pot Stocks Leave Canopy Behind as Deal Comes at ‘Great Cost’
Bloomberg · 07/08 16:34
Real Estate Is the Crisis Risk to Watch Now
Bloomberg · 06/21 04:00
Short-Sellers Target Biggest US Bitcoin ETF as Drawdown Deepens
Bloomberg · 05/27 12:58
SEC Planned Crackdown on ‘Misleading’ Funds Goes Far Beyond ESG
Bloomberg · 05/26 19:34
Flow Traders Executive Leaves After Swedish Ski Trip Incidents
Bloomberg · 05/10 08:00
More
Profile
Fund Name
Loncar Cancer Immunotherapy ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Rafael Zayas, Austin Wen